Treace Medical Concepts Inc expected to post a loss of 20  cents a share - Earnings Preview

Treace Medical Concepts

04/05/2022 03:11

* Treace Medical Concepts Inc  TMCI.OQ   TMCI.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 5. 
    * The Ponte Vedra Florida-based  company is expected to
report  a
39.2% increase in revenue to $26.033 million from $18.71 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Treace Medical
Concepts
Inc is for a loss of 20 cents per share. For the same quarter
last year, the company reported a loss of 7 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $30​, above​ its last closing price of $19.55.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.01       0.00       -0.12     Missed  -2,300
 Sep. 30 2021  -0.12       -0.12      -0.12     Met     0
 Jun. 30 2021  -0.12       -0.12      -0.10     Beat    16.7​
 Mar. 31 2021  -0.06       -0.06      -0.07     Missed  -16.7
 ​​                                                     
                                                        ​
 This summary was machine generated May 4 at 02:11 GMT.  All
figures in US dollars  unless otherwise stated